Diabetes

The study used Podimetrics SmartMats to take the temperature of participants’ feet and scan for signs of inflammation.

The company also announced a new partnership with Anthem. 

Along with funds announced a few months back, this brings the round's total to $20.8 million.

The study was conducted by Omada and Evidation Health and included 195 participants. 

Following a study looking into how adults living with Type 2 diabetes use technology to self-monitor lifestyle and health behaviors, researchers from the University of Texas Health Science Center at San Antonio found that technology-assisted self-monitoring was safe and effective in generating positive health outcomes.

The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.

Also: Centauri Health Solutions acquires HCFS; UCSF researchers detail smartphone PPG-based diabetes detection.

The company's diabetic foot ulcer detection platform is now available through 40 VA medical centers.

The arrangement comes alongside new eight-figure investments into the CGM maker, whose business looked to be in dire straits earlier this year.

Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.